Skip to main content

Find Clinical Trials

Home
Conditions
Cholangiocarcinoma

Clinical trial condition

Cholangiocarcinoma

Explore clinical trials studying Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.

491 public trials 153 recruiting studies

Refine in advanced search Browse all conditions

Cholangiocarcinoma trial results

Not Yet Recruiting

Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICC

NCT06648525

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +5 more
Locations: Harbin Medical University Harbin, Heilongjiang, China

View Trial Details

Not Yet Recruiting

Low-dose Gemcitabine and Cisplatin and PD-1/PD-L1 Antibody Therapy in Intrahepatic Cholangiocarcinoma

NCT06567600

Conditions: Adenocarcinoma, Carcinoma, Chemotherapy Effect, +6 more
Locations: The Third Affiliated Hospital of Sun Yat-Sen University Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Evaluation of Combined Modality Protons and Hepatic Transplantation for Hilar Cholangiocarcinoma

NCT06434493

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +3 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Living Donor Liver Transplantation for Intrahepatic Cholangiocarcinoma

NCT06539377

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Pemigatinib Combined With Durvalumab for Previously Treated Biliary Tract Carcinoma

NCT06530823

Conditions: Adenocarcinoma, Biliary Tract Carcinoma, Carcinoma, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Neratinib Tablets Monotherapy for Advanced Solid Tumors With HER2 Mutations

NCT06519110

Conditions: Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +30 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Phase 2 Study: OBI-833/OBI-821 Maintenance for Globo H+ Advanced Biliary Tract Cancer After Gemcitabine/Cisplatin

NCT06490198

Conditions: Adenocarcinoma, Carcinoma, Chemotherapy Effect, +5 more
Locations: Chang Gung Memorial Hospital Linkou Branch Taoyuan, Taiwan

Chang-Gung Memorial Hospital, Linkou Branch Taoyuan, Taiwan

View Trial Details

Not Yet Recruiting

A Single Arm, Single Centered Phase II Trial on the Combination of Adebrelimab, Surufatinib and Irinotecan Liposome-based HAIC in Advanced iCC

NCT06375642

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
Locations: Tianjin Cancer Hospital Airport Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Not Yet Recruiting

Digital Single-operator Cholangioscopy and Intraductal Ultrasound for Nonicteric Biliary Strictures

NCT06369896

Conditions: Adenocarcinoma, Biliary Stricture, Carcinoma, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Surufatinib Combined With Toripalimab and HAIC in the Treatment of Inoperable or Metastatic Intrahepatic Cholangiocarcinoma

NCT06313554

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
Locations: Not specified

View Trial Details